Kinase/phosphatase regulation of CYP7A1

Frontiers in Bioscience

Volumn 10, Issue 2, 2005, Pages 1678-1692

  Stroup, Diane ^a  

^a KENT STATE UNIVERSITY   (United States)

Author keywords

AMP activated protein kinase (AMPK); Bile Acids; Biochemistry; c Jun N terminal kinase (JNK); Cross Talk; CYP7A1; Extracellular regulated kinase (ERK); Review; Signal Transduction

Indexed keywords

BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450 7A1; CYTOCHROME P450 ISOENZYME; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BILE ACID SYNTHESIS; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; DISEASE COURSE; ENZYME ACTIVITY; GENE CONTROL; HUMAN; LIPID METABOLISM; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 17244375261     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1652     Document Type: Article

References (172)

1. Gebhardt R. & F. Gaunitz: Cell-cell interactions in the regulation of the expression of hepatic enzymes. Cell Biol Toxicol 13, 263-273 (1997)
2. Massimi M., S. R. Lear, S. L. Huling, A. L. Jones & S. K. Erickson: Cholesterol 7alpha-hydroxylase (CYP7A): patterns of messenger RNA expression during rat liver development. Hepatology 28, 1064-1072 (1998)
3. Chiang J. Y. & D. Stroup: Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter. J Biol Chem 269, 17502-17507 (1994)
4. Crestani M., D. Stroup & J. Y. Chiang: Hormonal regulation of the cholesterol 7 alpha-hydroxylase gene (CYP7). J Lipid Res 36, 2419-2432 (1995)
5. Wang D. P., D. Stroup, M. Marrapodi, M. Crestani, G. Galli & J. Y. Chiang: Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene (CYP7A) in HepG2 cells. J Lipid Res 37, 1831-1841 (1996)
6. Jelinek D. F., S. Andersson, C. A. Slaughter & D. W. Russell: Cloning and regulation of cholesterol 7alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem 265, 8190-8197 (1990)
7. Li Y. C., D. P. Wang & J. Y. Chiang: Regulation of cholesterol 7 alpha-hydroxylase in the liver. Cloning, sequencing, and regulation of cholesterol 7 alpha-hydroxylase mRNA. J Biol Chem 265, 12012-12019 (1990)
8. Sundseth S. S. & D. J. Waxman: Hepatic P-450 cholesterol 7alpha-hydroxylase. Regulation in vivo at the protein and mRNA level in response to mevalonate, diurnal rhythm, and bile acid feedback. J Biol Chem 265, 15090-15095 (1990)
9. Hoekman M. F., J. M. Rientjes, J. Twisk, R. J. Planta, H. M. Princen & W. H. Mager: Transcriptional regulation of the gene encoding cholesterol 7 alpha- hydroxylase in the rat [published erratum appears in Gene 1994 Apr 20;141(2):309-10]. Gene 130, 217-223 (1993)
10. Crestani M., W. G. Karam & J. Y. Chiang: Effects of bile acids and steroid/thyroid hormones on the expression of cholesterol 7 alpha-hydroxylase mRNA and the CYP7 gene in HepG2 cells. Biochem Biophys Res Commun 198, 546-553 (1994)
11. Taniguchi T., J. Chen & A. D. Cooper: Regulation of cholesterol 7 alpha-hydroxylase gene expression in Hep-G2 cells. Effect of serum, bile salts, and coordinate and noncoordinate regulation with other sterol-responsive genes. J Biol Chem 269, 10071-10078 (1994)
12. Spady D. K., J. A. Cuthbert, M. N. Willard & R. S. Meidell: Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha- hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest 96, 700-709 (1995)
13. Cooper A. D., J. Chen, M. J. Botelho-Yetkinler, Y. Cao, T. Taniguchi & B. Levy-Wilson: Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7alpha-hydroxylase gene. J Biol Chem 272, 3444-3452 (1997)
14. Stravitz R. T., P. B. Hylemon, D. M. Heuman, L. R. Hagey, C. D. Schteingart, H.-T. Ton-Nu, A. F. Hoffman & Z. R. Vlahcevic: Transcriptional regulation of cholesterol 7alpha-hydroxylase mRNA by conjugated bile acids in primary cultures of rat hepatocytes. J Biol Chem 268, 13987-13993 (1993)
15. Twisk J., M. F. Hoekman, L. M. Muller, T. Iida, T. Tamaru, A. Ijzerman, W. H. Mager & H. M. Princen: Structural aspects of bile acids involved in the regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase. Eur J Biochem 228, 596-604 (1995)
16. Stroup D., M. Crestani & J. Y. Chiang: Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. Am J Physiol 273, G508-517 (1997)
17. Stroup D. & J. Y. L. Chiang: The Bile Acid Reponse of Cholesterol 7alpha-hydroxylase Gene Proximal Promoter May Not be Mediated Through One Element. Advances in Gene Technology: Protein Engineering and Structural Biology 6, 76 (1995)
18. Stroup D. & J. Y. Chiang: HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). J Lipid Res 41, 1-11 (2000)
19. Foti D., D. Stroup & J. Y. Chiang: Basic transcription element binding protein (BTEB) transactivates the cholesterol 7 alpha-hydroxylase gene (CYP7A). Biochem Biophys Res Commun 253, 109-113 (1998)
20. Nitta M., S. Ku, C. Brown, A. Y. Okamoto & B. Shan: CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene. Proc Natl Acad Sci U S A 96, 6660-6665 (1999)
21. Chiang J. Y.: Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 23, 443-463 (2002)
22. Russell D. W.: The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72, 137-174 (2003)
23. Chiang J. Y.: Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 40, 539-551 (2004)
24. Ishibashi S., M. Schwarz, P. K. Frykman, J. Herz & D. W. Russell: Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem 271, 18017-18023 (1996)
25. Wu Z., K. O. Martin, N. B. Javitt & J. Y. Chiang: Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 40, 2195-2203 (1999)
26. Li-Hawkins J., E. G. Lund, A. D. Bronson & D. W. Russell: Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J Biol Chem 275, 16543-16549 (2000)
27. Pullinger C. R., C. Eng, G. Salen, S. Shefer, A. K. Batta, S. K. Erickson, A. Verhagen, C. R. Rivera, S. J. Mulvihill, M. J. Malloy & J. P. Kane: Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110, 109-117 (2002)
28. Anderson S., D. L. Davis, H. Dahlback, H. Jornvall & D. W. Russell: Cloning, structure, and expression of the mitochondrial cytochrome P450 sterol 27-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 264, 8222-8229 (1989)
29. Axen E., H. Postlind, H. Sjoberg & K. Wikvall: Liver mitochondrial cytochrome P450 CYP27 and recombinant-expressed human CYP27 catalyze 1alpha- hydroxylation of 25-hydroxyvitamin D3. Proc Natl Acad Sci USA 91, 10014-10018 (1994)
30. Quan G., C. Xie, J. M. Dietschy & S. D. Turley: Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 146, 87-98 (2003)
31. Bodin K., L. Bretillon, Y. Aden, L. Bertilsson, U. Broome, C. Einarsson & U. Diczfalusy: Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem 276, 38685-38689 (2001)
32. Schwarz M., D. W. Russell, J. M. Dietschy & S. D. Turley: Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. J Lipid Res 42, 1594-1603 (2001)
33. Bjorkhem I., Z. Araya, M. Rudling, B. Angelin, C. Einarsson & K. Wikvall: Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J Biol Chem 277, 26804-26807 (2002)
34. Tiemann M., Z. Han, R. Soccio, J. Bollineni, S. Shefer, E. Sehayek & J. L. Breslow: Cholesterol feeding of mice expressing cholesterol 7alpha-hydroxylase increases bile acid pool size despite decreased enzyme activity. Proc Natl Acad Sci U S A 101, 1846-1851 (2004)
35. Bjorkhem I., O. Andersson, U. Diczfalusy, B. Sevastik, R.-j. Xiu, C. Duan & E. Lund: Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA 91, 8592-8596 (1994)
36. Li-Hawkins J., E. G. Lund, S. D. Turley & D. W. Russell: Disruption of the oxysterol 7alpha-hydroxylase gene in mice. J Biol Chem 275, 16536-16542 (2000)
37. Janowski B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey & D. J. Mangelsdorf: Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci U S A 96, 266-271 (1999)
38. Repa J. J., E. G. Lund, J. D. Horton, E. Leitersdorf, D. W. Russell, J. M. Dietschy & S. D. Turley: Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J Biol Chem 275, 39685-39692 (2000)
39. Privalsky M. L.: The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66, 315-360 (2004)
40. Zhang Y. & M. L. Dufau: Gene silencing by nuclear orphan receptors. Vitam Horm 68, 1-48 (2004)
41. Hayhurst G. P., Y. H. Lee, G. Lambert, J. M. Ward & F. J. Gonzalez: Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21, 1393-1403. (2001)
42. Stoffel M. & S. A. Duncan: The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci U S A 94, 13209-13214 (1997)
43. Bulla G. A.: Extinction of alpha1-antitrypsin expression in cell hybrids is independent of HNF1alpha and HNF4 and involves both promoter and internal DNA sequences. Nucleic Acids Res 27, 1190-1197 (1999)
44. Wan Y. J., Y. Cai, C. Cowan & T. R. Magee: Fatty acyl-CoAs inhibit retinoic acid-induced apoptosis in Hep3B cells. Cancer Lett 154, 19-27 (2000)
45. Viollet B., A. Kahn & M. Raymondjean: Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol Cell Biol 17, 4208-4219 (1997)
46. Yoshida E., S. Aratani, H. Itou, M. Miyagishi, M. Takiguchi, T. Osumu, K. Murakami & A. Fukamizu: Functional association between CBP and HNF4 in transactivation. Biochem Biophys Res Commun 241, 664-669 (1997)
47. Wang J. C., P. E. Stromstedt, T. Sugiyama & D. K. Granner: The phosphoenolpyruvate carboxykinase gene glucocorticoid response unit: identification of the functional domains of accessory factors HNF3 beta (hepatic nuclear factor-3 beta) and HNF4 and the necessity of proper alignment of their cognate binding sites. Mol Endocrinol 13, 604-618 (1999)
48. Wang J. C., J. M. Stafford & D. K. Granner: SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J Biol Chem 273, 30847-30850 (1998)
49. Eeckhoute J., P. Formstecher & B. Laine: Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4alpha (HNF4alpha) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator. Mol Endocrinol 15, 1200-1210. (2001)
50. Yamagata K., H. Furuta, N. Oda, P. J. Kaisaki, S. Menzel, N. J. Cox, S. S. Fajans, S. Signorini, M. Stoffel & G. I. Bell: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity- onset diabetes of the young (MODY1). Nature 384, 458-460. (1996)
51. Suaud L., Y. Hemimou, P. Formstecher & B. Laine: Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes 48, 1162-1167. (1999)
52. Yamagata K., N. Oda, P. J. Kaisaki, S. Menzel, H. Furuta, M. Vaxillaire, L. Southam, R. D. Cox, G. M. Lathrop, V. V. Boriraj, X. Chen, N. J. Cox, Y. Oda, H. Yano, M. M. Le Beau, S. Yamada, H. Nishigori, J. Takeda, S. S. Fajans, A. T. Hattersley, N. Iwasaki, T. Hansen, O. Pedersen, K. S. Polonsky, G. I. Bell & et al.: Mutations in the hepatocyte nuclear factor-1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384, 455-458. (1996)
53. Shih D. Q., M. Bussen, E. Sehayek, M. Ananthanarayanan, B. L. Shneider, F. J. Suchy, S. Shefer, J. S. Bollileni, F. J. Gonzalez, J. L. Breslow & M. Stoffel: Hepatocyte nuclear factor-1 alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27, 375-382. (2001)
54. Zhang M. & J. Y. Chiang: Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression. J Biol Chem 276, 41690-41699 (2001)
55. von Hofsten J., I. Jones, J. Karlsson & P. E. Olsson: Developmental expression patterns of FTZ-F1 homologues in zebrafish (Danio rerio). Gen Comp Endocrinol 121, 146-155. (2001)
56. Fayard E., J. Auwerx & K. Schoonjans: LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol 14, 250-260 (2004)
57. Lee Y. K., K. L. Parker, H. S. Choi & D. D. Moore: Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers. J Biol Chem 274, 20869-20873 (1999)
58. Shamay M., R. Agami & Y. Shaul: HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. Oncogene 20, 6811-6819. (2001)
59. Rausa F. M., L. Galarneau, L. Belanger & R. H. Costa: The nuclear receptor fetoprotein transcription factor is coexpressed with its target gene HNF-3beta in the developing murine liver, intestine and pancreas. Mech Dev 89, 185-188 (1999)
60. Galarneau L., J. F. Pare, D. Allard, D. Hamel, L. Levesque, J. D. Tugwood, S. Green & L. Belanger: The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. Mol Cell Biol 16, 3853-3865 (1996)
61. del Castillo-Olivares A. & G. Gil: Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. J Biol Chem 275, 17793-17799. (2000)
62. Lee Y. K. & D. D. Moore: Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 (LRH-1) by the orphan small heterodimer partner (SHP). J Biol Chem 19, 19 (2001)
63. Goodwin B., S. A. Jones, R. R. Price, M. A. Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, P. R. Maloney, T. M. Willson & S. A. Kliewer: A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6, 517-526 (2000)
64. Lu T. T., M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx & D. J. Mangelsdorf: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6, 507-515 (2000)
65. del Castillo-Olivares A. & G. Gil: Differential effects of sterol regulatory binding proteins 1 and 2 on sterol 12 alpha-hydroxylase. SREBP-2 suppresses the sterol 12 alpha-hydroxylase promoter. J Biol Chem 277, 6750-6757 (2002)
66. Chen W., E. Owsley, Y. Yang, D. Stroup & J. Y. Chiang: Nuclear receptor-mediated repression of human cholesterol 7alpha- hydroxylase gene transcription by bile acids. J Lipid Res 42, 1402-1412. (2001)
67. del Castillo-Olivares A. & G. Gil: Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription. Nucleic Acids Res 28, 3587-3593. (2000)
68. del Castillo-Olivares A. & G. Gil: Suppression of sterol 12alpha-hydroxylase transcription by the short heterodimer partner: insights into the repression mechanism. Nucleic Acids Res 29, 4035-4042. (2001)
69. Gerbod-Giannone M. C., A. Del Castillo-Olivares, S. Janciauskiene, G. Gil & P. B. Hylemon: Suppression of cholesterol 7alpha-hydroxylase transcription and bile acid synthesis by an alpha1-antitrypsin peptide via interaction with alpha1-fetoprotein transcription factor. J Biol Chem 277, 42973-42980 (2002)
70. Lee Y. K. & D. D. Moore: Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner. J Biol Chem 277, 2463-2467 (2002)
71. Yang Y., M. Zhang, G. Eggertsen & J. Y. Chiang: On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha. Biochim Biophys Acta 1583, 63-73. (2002)
72. Forman B. M., E. Goode, J. Chen, A. E. Oro, D. J. Bradley, T. Perlmann, D. J. Noonan, L. T. Burka, T. McMorris, W. W. Lamph, R. W. Evans & C. Weinberger: Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687-693 (1995)
73. Mangelsdorf D. J. & R. M. Evans: The RXR heterodimers and orphan receptors. Cell 83, 841-850 (1995)
74. Makishima M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf & B. Shan: Identification of a nuclear receptor for bile acids. Science 284, 1362-1365 (1999)
75. Parks D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore & J. M. Lehmann: Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368 (1999)
76. Wang H., J. Chen, K. Hollister, L. C. Sowers & B. M. Forman: Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3, 543-553 (1999)
77. Howard W. R., J. A. Pospisil, E. Njolito & D. J. Noonan: Catabolites of Cholesterol Synthesis Pathways and Forskolin as Activators of the Farnesoid X-Activated Nuclear Receptor. Toxicol Appl Pharmacol 163, 195-202 (2000)
78. Hanley K., Y. Jiang, D. Crumrine, N. M. Bass, R. Appel, P. M. Elias, M. L. Williams & K. R. Feingold: Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 100, 705-712 (1997)
79. Williams M. L., K. Hanley, P. M. Elias & K. R. Feingold: Ontogeny of the epidermal permeability barrier. J Investig Dermatol Symp Proc 3, 75-79 (1998)
80. Sinal C. J., M. Tohkin, M. Miyata, J. M. Ward, G. Lambert & F. J. Gonzalez: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102, 731-744 (2000)
81. Grober J., I. Zaghini, H. Fujii, S. A. Jones, S. A. Kliewer, T. M. Willson, T. Ono & P. Besnard: Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J Biol Chem 274, 29749-29754 (1999)
82. Urizar N. L., D. H. Dowhan & D. D. Moore: The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem (2000)
83. Claudel T., E. Sturm, H. Duez, I. P. Torra, A. Sirvent, V. Kosykh, J. C. Fruchart, J. Dallongeville, D. W. Hum, F. Kuipers & B. Staels: Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest 109, 961-971 (2002)
84. Kerr T. A., S. Saeki, M. Schneider, K. Schaefer, S. Berdy, T. Redder, B. Shan, D. W. Russell & M. Schwarz: Loss of Nuclear Receptor SHP Impairs but Does Not Eliminate Negative Feedback Regulation of Bile Acid Synthesis. Dev Cell 2, 713-720 (2002)
85. Davis R. A., J. H. Miyake, T. Y. Hui & N. J. Spann: Regulation of cholesterol-7alpha-hydroxylase. Barely missing a shp. J Lipid Res 43, 533-543 (2002)
86. Chen F., L. Ma, P. A. Dawson, C. J. Sinai, E. Sehayek, F. J. Gonzalez, J. Breslow, M. Ananthanarayanan & B. L. Shneider: Liver receptor homologue-1 mediates species-and cell line-specific bile acid dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem (2002)
87. Wang L., Y. K. Lee, D. Bundman, Y. Han, S. Thevananther, C. S. Kim, S. S. Chua, P. Wei, R. A. Heyman, M. Karin & D. D. Moore: Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2, 721-731 (2002)
88. Barletta F., P. Dhawan & S. Christakos: Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription. Am J Physiol Endocrinol Metab 286, E598-608 (2004)
89. Irrcher I., P. J. Adhihetty, T. Sheehan, A. M. Joseph & D. A. Hood: PPARgamma coactivator-1 alpha expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations. Am J Physiol Cell Physiol 284, C1669-1677 (2003)
90. Shin D. J., J. A. Campos, G. Gil & T. F. Osborne: PGC-1alpha activates CYP7A1 and bile acid biosynthesis. J Biol Chem 278, 50047-50052 (2003)
91. Ruderman N. B., A. K. Saha & E. W. Kraegen: Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144, 5166-5171 (2003)
92. Terada S., M. Goto, M. Kato, K. Kawanaka, T. Shimokawa & I. Tabata: Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun 296, 350-354 (2002)
93. Rao Y. P., E. J. Studer, R. T. Stravitz, S. Gupta, L. Qiao, P. Dent & P. B. Hylemon: Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes. Hepatology 35, 307-314 (2002)
94. Crestani M., A. Sadeghpour, D. Stroup, G. Galli & J. Y. Chiang: The opposing effects of retinoic acid and phorbol esters converge to a common response element in the promoter of the rat cholesterol 7 alpha- hydroxylase gene (CYP7A). Biochem Biophys Res Commun 225, 585-592 (1996)
95. De Fabiani E., N. Mitro, A. C. Anzulovich, A. Pinelli, G. Galli & M. Crestani: The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276, 30708-30716 (2001)
96. Li-Hawkins J., M. Gafvels, M. Olin, E. G. Lund, U. Andersson, G. Schuster, I. Bjorkhem, D. W. Russell & G. Eggertsen: Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest 110, 1191-1200 (2002)
97. Gupta S., R. T. Stravitz, P. Dent & P. B. Hylemon: Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway J Biol Chem 276, 15816-15822 (2001)
98. Narayanan R., V. A. Sepulveda, M. Falzon & N. L. Weigel: The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific. J Biol Chem 279, 47298-47310 (2004)
99. Hsieh J. C., H. T. Dang, M. A. Galligan, G. K. Whitfield, C. A. Haussler, P. W. Jurutka & M. R. Haussler: Phosphorylation of human vitamin D receptor serine-182 by PKA suppresses 1,25(OH)2D3-dependent transactsvation. Biochem Biophys Res Commun 324, 801-809 (2004)
100. Desclozeaux M., I. N. Krylova, F. Horn, R. J. Fletterick & H. A. Ingraham: Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol Cell Biol 22, 7193-7203 (2002)
101. Aoki H., P. M. Kang, J. Hampe, K. Yoshimura, T. Noma, M. Matsuzaki & S. Izumo: Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 277, 10244-10250 (2002)
102. Adcock I. M. & G. Caramori: Cross-talk between proinflammatory transcription factors and glucocorticoids. Immunol Cell Biol 79, 376-384 (2001)
103. Gupta S., R. Natarajan, S. G. Payne, E. J. Studer, S. Spiegel, P. Dent & P. B. Hylemon: Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation. J Biol Chem 279, 5821-5828 (2004)
104. Srinivasan K. & K. Sambaiah: The effect of spices on cholesterol 7 alpha-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Int J Vitam Nutr Res 61, 364-369 (1991)
105. Crossthwaite A. J., H. Valli & R. J. Williams: Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones. J Neurochem 88, 1127-1139 (2004)
106. Gyles S. L., C. J. Burns, B. J. Whitehouse, D. Sugden, P. J. Marsh, S. J. Persaud & P. M. Jones: ERKs regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene. J Biol Chem 276, 34888-34895 (2001)
107. Fang Y., S. I. Han, C. Mitchell, S. Gupta, E. Studer, S. Grant, P. B. Hylemon & P. Dent: Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 40, 961-971 (2004)
108. Beg Z. H., J. A. Stonik & H. B. Brewer, Jr.: 3-Hydroxy-3- methylglutaryl coenzyme A reductase: regulation of enzymatic activity by phosphorylation and dephosphorylation. Proc Natl Acad Sci U S A 75, 3678-3682. (1978)
109. Beg Z. H., J. A. Stonik & H. B. Brewer, Jr.: Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review. Metabolism 36, 900-917. (1987)
110. Clarke P. R. & D. G. Hardie: Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. Embo J 9, 2439-2446. (1990)
111. Aguan K., J. Scott, C. G. See & N. H. Sarkar: Characterization and chromosomal localization of the human homologue of a rat AMP-activated protein kinase-encoding gene: a major regulator of lipid metabolism in mammals. Gene 149, 345-350 (1994)
112. Dale S., W. A. Wilson, A. M. Edelman & D. G. Hardie: Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Lett 361, 191-195. (1995)
113. Arebalo R. E., J. E. Hardgrave, B. J. Noland & T. J. Scallen: In vivo regulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase: enzyme phosphorylation as an early regulatory response after intragastric administration of mevalonolactone. Proc Natl Acad Sci U S A 77, 6429-6433. (1980)
114. Feingold K. R., M. H. Wiley, A. H. Moser, S. R. Lear & M. D. Siperstein: Activation of HMG-CoA reductase by microsomal phosphatase. J Lipid Res 24, 290-296. (1983)
115. Bergeron R., S. F. Previs, G. W. Cline, P. Perret, R. R. Russell, 3rd, L. H. Young & G. I. Shulman: Effect of 5-aminoimidazole-4-carboxamide-1-beta- D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50, 1076-1082 (2001)
116. Chen H. C., G. Bandyopadhyay, M. P. Sajan, Y. Kanoh, M. L. Standaert, R. V. Farese, Jr. & R. V. Farese: Activation of ERK pathway and atypical protein kinase C isoforms in exercise- and AICAR-stimulated glucose transport. J Biol Chem (2002)
117. Stravitz R. T., Y. Rao, Z. R. Vlahcevic, E. C. Gurley & P. B. Hylemon: Protein kinase C activation/cellular redistribution and cholesterol 7alpha-hydroxylase mRNA repression by bile acids in rat hepatocytes. Hepatology 22, 239A (1995)
118. Lochhead P. A., I. P. Salt, K. S. Walker, D. G. Hardie & C. Sutherland: 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49, 896-903 (2000)
119. Leclerc I., C. Lenzner, L. Gourdon, S. Vaulont, A. Kahn & B. Viollet: Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of amp-activated protein kinase. Diabetes 50, 1515-1521. (2001)
120. Zhou G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M. F. Hirshman, L. J. Goodyear & D. E. Moller: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167-1174 (2001)
121. Li W., A. P. Scott, M. J. Siefkes, H. Yan, Q. Liu, S. S. Yun & D. A. Gage: Bile Acid secreted by male sea lamprey that acts as a sex pheromone. Science 296, 138-141 (2002)
122. Chico Y., O. Fresnedo, K. Botham, M. Lacort & B. Ochoa: Regulation of bile acid synthesis by estradiol and progesterone in primary cultures of rat hepatocytes. Exp Clin Endocrinol Diabetes 104, 137-144 (1996)
123. Scarpello J. H., E. Hodgson & H. C. Hewlett: Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet Med 15, 651-656 (1998)
124. Sewer M. B. & M. R. Waterman: cAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J Biol Chem 278, 8106-8111 (2003)
125. Han S. I., E. Studer, S. Gupta, Y. Fang, L. Qiao, W. Li, S. Grant, P. B. Hylemon & P. Dent: Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes. Hepatology 39, 456-463 (2004)
126. Qiao L., S. I. Han, Y. Fang, J. S. Park, S. Gupta, D. Gilfor, G. Amorino, K. Valerie, L. Sealy, J. F. Engelhardt, S. Grant, P. B. Hylemon & P. Dent: Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol 23, 3052-3066 (2003)
127. Higuchi H., A. Grambihler, A. Canbay, S. F. Bronk & G. J. Gores: Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279, 51-60 (2004)
128. Graf D., A. K. Kurz, R. Reinehr, R. Fischer, G. Kircheis & D. Haussinger: Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology 36, 829-839 (2002)
129. Graf D., A. K. Kurz, R. Fischer, R. Reinehr & D. Haussinger: Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology 122, 1411-1427 (2002)
130. Qiao L., A. Yacoub, E. Studer, S. Gupta, X. Y. Pei, S. Grant, P. B. Hylemon & P. Dent: Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology 35, 779-789 (2002)
131. Holt J. A., G. Luo, A. N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, Y. Wang da, T. A. Mansfield, S. A. Kliewer, B. Goodwin & S. A. Jones: Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17, 1581-1591 (2003)
132. Andreka P., J. Zang, C. Dougherty, T. I. Slepak, K. A. Webster & N. H. Bishopric: Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 88, 305-312 (2001)
133. Ktistaki E., T. Ktistaki, E. Papadogeorgaki & I. Talianidis: Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartiments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci USA 92, 9876-9880 (1995)
134. Gourdon L., D. Q. Lou, M. Raymondjean, M. Vasseur-Cognet & A. Kahn: Negative cyclic AMP response elements in the promoter of the L-type pyruvate kinase gene. FEBS Lett 459, 9-14 (1999)
135. Jiang G., L. Nepomuceno, Q. Yang & F. M. Sladek: Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4. Arch Biochem Biophys 340, 1-9 (1997)
136. Hong Y. H., U. S. Varanasi, W. Yang & T. Leff: AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 278, 27495-27501 (2003)
137. Li D., T. L. Zimmerman, S. Thevananther, H. Y. Lee, J. M. Kurie & S. J. Karpen: Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem 111, 31416-31422 (2002)
138. Cesario R. M., K. Klausing, H. Razzaghi, D. Crombie, D. Rungta, R. A. Heyman & D. S. Lala: The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol Endocrinol 15, 1360-1369 (2001)
139. Sanghvi A., E. Grassi, V. Warty, W. Diven, C. Wight & R. Lester: Reversible activation-inactivation of cholesterol 7alpha-hydroxylase possibly due to phosphorylation-dephosphorylation. Biochem Biophys Res Commun 103, 886-892 (1981)
140. Goodwin C. D., B. W. Cooper & S. Margolis: Rat liver cholesterol 7alpha-hydroxylase: Modulation of enzyme activity by changes in phosphorylation state. J Biol Chem 257, 4469-4472 (1982)
141. Scallen T. J. & A. Sanghvi: Regulation of three key enzymes in cholesterol metabolism by phosphorylation/dephosphorylation. Proc Natl Acad Sci U S A 80, 2477-2480 (1983)
142. Nguyen L. B., S. Shefer, G. Salen, J. Y. Chiang & M. Patel: Cholesterol 7alpha-hydroxylase activities from human and rat liver are modulated in vitro posttranslationally by phosphorylation/dephosphorylation. Hepatology 24, 1468-1474 (1996)
143. Berglund L., I. Bjorkhem, B. Angelin & K. Einarsson: Evidence against in vitro modulation of rat liver cholesterol 7 alpha- hydroxylase activity by phosphorylation-dephosphorylation: comparison with hydroxymethylglutaryl CoA reductase. Acta Chem Scand [B] 40, 457-461 (1986)
144. Jelinek D. & D. W. Russell: Structure of the rat gene encoding
145. Li Y. C., D. P. Wang & J. Y. L. Chiang: Regulation of cholesterol 7alpha-hydroxylase in the liver: Cloning, sequencing and regulation of cholesterol 7alpha-hydroxylase mRNA. J Biol Chem 265, 12012-12019 (1990)
146. Ramirez M. I., D. Karaoglu, D. Haro, C. Barillas, R. Bashirzadeh & G. Gil: Cholesterol and bile acid regulate cholesterol 7alpha-hydroxylase expression at the transcriptional level in culture and in transgenic mice. Mol Cell Biol 14, 2809-2821 (1994)
147. Hoekman M. F. M., J. M. J. Rientjes, J. Twisk, R. J. Planta. II. M. G. Princen & W. H. Mager: Transcriptional regulation of the gene encoding cholesterol 7alpha-hydroxylase in the rat. Gene 130, 217-223 (1993)
148. Crestani M., W. G. Karam & J. Y. L. Chiang: Effects of bile acids and steroid/thyroid hormones on the expression of cholesterol 7alpha-hydroxylase mRNA and the CYP7 gene in HepG2 cells. Biochem Biophys Res Commun 198, 546-553 (1994)
149. Taniguchi T., J. Chen & A. D. Cooper: Regulation of cholesterol 7alpha-hydroxylase gene expression in HepG2 cells. J Biol Chem 269, 10071-10078 (1994)
150. Wang D.-P., D. Stroup, M. Marrapodi, M. Crestani, G. Galli & J. Y. L. Chiang: Transcriptional regulation of the human cholesterol 7alpha-hydroxylase gene (Cyp7A) in HepG2 cells. J Lipid Research 37, 1831-1841 (1996)
151. Cooper A. D., J. Chen, M. J. Botelho-Yetkinler, Y. Cao, T. Taniguchi & B. Levy-Wilson: Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7alpha-hydroxylase gene. J Biol Chem 272, 3444-3452 (1997)
152. Twisk J., M. F. M. Hoekman, W. H. Mager, A. F. M. Moorman, P. A. J. de Boer, L. Scheja, H. M. G. Princen & R. Gebhardt: Heterogeneous expression of cholesterol 7alpha-hydroxylase and steroid 27-hydroxylase in the rat liver lobulus. J Clin Invest 95, 1235-1243 (1995)
153. Pandak W. M., Z. R. Vlahcevic, D. M. Heuman, K. S. Redford, J. Y. L. Chiang & P. B. Hylemon: Effect of different bile salts on the steady-state mRNA levels and transcriptional activity of cholesterol 7α-hydroxylase. Hepatology 19, 941-947 (1994)
154. Agellon L. B. & S. K. Cheema: The 3′-untranslated region of the mouse cholesterol 7alpha-hydroxylase mRNA contains elements responsive to post-transcriptional regulation by bile acids. Biochem J 328, 393-399 (1997)
155. Tang P. M. & J. Y. L. Chiang: Modulation of reconstituted cholesterol 7 alpha-hydroxylase by phosphatase and protein kinase. Biochem Biophys Res Commun 134, 797-802 (1986)
156. Nguyen L. B., S. Shefer, G. Salen, J. Y. Chiang, L, & M. Patel: Cholesterol 7alpha-hydroxylase activities from human and rat liver are modulated in vitro posttranslationally by phosphorylation/dephosphorylation. Hepatology 24, 1468-1474 (1996)
157. Hawley S. A., M. A. Selbert, E. G. Goldstein, A. M. Edelman, D. Carling & D. G. Hardie: 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270, 27186-27191 (1995)
158. Hassan A. S. & B. L. Ventling: Effect of diabetes on partially purified hepatic cholesterol 7 alpha- hydroxylase, the rate-limiting enzyme of bile acid biosynthesis. Res Commun Chem Pathol Pharmacol 58, 41-51 (1987)
159. Lathe R.: Steroid and sterol 7-hydroxylation: ancient pathways. Steroids 67, 967-977 (2002)
160. Rodrigues C. M., S. Sola, Z. Nan, R. E. Castro, P. S. Ribeiro, W. C. Low & C. J. Steer: Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci U S A 100, 6087-6092 (2003)
161. Keene C. D., C. M. Rodrigues, T. Eich, M. S. Chhabra, C. J. Steer & W. C. Low: Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A 99, 10671-10676 (2002)
162. Condon J. R., V. Robinson, M. I. Suleman, V. S. Fan & M. D. McKeown: The cause and treatment of postvagotomy diarrhoea. Br J Surg 62, 309-312 (1975)
163. Molloy A. M. & G. H. Tomkin: Altered bile in diabetic diarrhoea. Br Med J 2, 1462-1463 (1978)
164. Nakamura T., K. Imamura, F. Kasai, F. Tsushima, H. Kikuchi & K. Takebe: Fecal excretions of hydroxy fatty acid and bile acid in diabetic diarrheal patients. J Diabetes Complications 7, 8-11 (1993)
165. Nakamura T., T. Suda & M. Kon: Pathophysiology and treatment of diabetic diarrhea. J Smooth Muscle Res 32, 27-42 (1996)
166. Subbiah M. T. & R. L. Yunker: Evidence for the presence of non-lipoprotein factors in diabetic serum capable of stimulating rat hepatic cholesterol-7 alpha-hydroxylase in vitro. Biochem Biophys Res Commun 121, 743-748 (1984)
167. Stone J. L., J. B. Braunstein, T. M. Beaty, R. A. Sanders & J. B. Watkins, 3rd: Hepatobiliary excretion of bile acids and rose bengal in streptozotocin-induced and genetic diabetic rats. J Pharmacol Exp Ther 281, 412-419 (1997)
168. Twisk J., M. F. Hoekman, E. M. Lehmann, P. Meijer, W. H. Mager & H. M. Princen: Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27- hydroxylase gene transcription. Hepatology 21, 501-510 (1995)
169. Mokdad A. H., B. A. Bowman, E. S. Ford, F. Vinicor, J. S. Marks & J. P. Koplan: The continuing epidemics of obesity and diabetes in the United States. Jama 286, 1195-1200 (2001)
170. Major cardiovascular disease (CVD) during 1997-1999 and major CVD hospital discharge rates in 1997 among women with diabetes - United States. MMWR Morb Mortal Wkly Rep 50, 948-954 (2001)
171. Harris M. I.: Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 23, 754-758 (2000)
172. Gylling H. & T. A. Miettinen: Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care 20, 90-95 (1997)